Neutralising antibodies targeting PDPN showed inhibition of tumour growth and metastasis in xenograft models for osteosarcoma, oral cancer, and malignant pleural mesothelioma (MPM) [313,314,315], supporting clinical assessment of anti-PDPN antibodies in the future
The tripeptide enters cells via PepT1 transporter and reduces pro-inflammatory cytokine secretion in intestinal epithelial cells and macrophages[14]
While clinical studies have explored its use in topical skincare and wound care, the 100mg formulation provides a high-concentration, cost-effective foundation for longitudinal studies, dose-response curves, and combination protocols particularly when paired with BPC-157 or TB-500
Nationwide Availability Our compounded GHK-Cu cream is available via prescription to patients and healthcare providers across multiple states
Formulated in a stabilized pre-mixed injection pen for SubQ administration , GHK-Cu ensures high systemic bioavailability and precise dosing control under research conditions
Free shipping